已收盘 05-12 16:00:00 美东时间
0.000
0.00%
NeuroPace, Inc., a medical technology company focused on treating epilepsy, issued a statement responding to the Centers for Medicare & Medicaid Services (CMS) decision not to finalize the reassignment of epilepsy with neurostimulator cases in the FY 2026 Inpatient Prospective Payment System (IPPS) rule. Joel Becker, CEO of NeuroPace, expressed appreciation for CMS maintaining the current MS-DRG assignment for RNS® System procedures under MS-DRG ...
08-01 11:30
Waltham, MA, Dec. 16, 2021 (GLOBE NEWSWIRE) -- LAVA Medtech Acquisition Corp. (...
2021-12-17 04:07
Waltham, MA , Oct. 26, 2021 (GLOBE NEWSWIRE) -- LAVA Medtech Acquisition Corp. ...
2021-10-27 06:42
05:36 AM EDT, 10/18/2021 (MT Newswires) -- LAVA Medtech Acquisition Corp. (LVAC...
2021-10-18 17:36